Dendrobium DhLCYB gene and application thereof in instantaneous regulation of flower color

VIGS technology inhibits the DhLCYB gene in Dendrobium orchid, significantly changes the type and redness of the flower color, solves the problem of insufficient color diversity of Dendrobium orchid, and achieves the ornamental and long-lasting effect of the diverse color of Dendrobium orchid.

CN119082095APending Publication Date: 2024-12-06TROPICAL CORP STRAIN RESOURCE INST CHINESE ACAD OF TROPICAL AGRI SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411437091.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-15
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art has failed to effectively study and breed pure red, orange and sky blue colors in Dendrobium orchids, and lacks ornamental research on the LCYB gene of Dendrobium orchid.

Method used

Virus-induced gene silencing (VIGS) technology is used to construct the VIGS vector of the DhLCYB gene to inhibit the expression of DhLCYB protein function or nucleic acid molecules in DhLCYB orchid, and to change the color of the color, including constructing VIGS vector, transferring Agrobacterium, and introducing DhLCYB orchid. Leaf, achieve color changes.

Benefits of technology

It significantly changed the types and redness of the dendrobium orchid flower colors, increased the diversity of the flower colors, and the performance of different plants and flowers is different, with strong ornamentality, and the effect of changing the flower colors lasts, without damage to the flower shape.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention discloses a dendrobium DhLCYB gene and application of the dendrobium DhLCYB gene in instantaneous regulation of flower color. The protein provided by the invention is any one of the following proteins: A1) a protein comprising an amino acid residue as shown in a sequence 2 in a sequence table; a2) a protein which is obtained by substituting and / or deleting and / or adding one or more amino acid residues of the amino acid sequence shown in the sequence 2, has the same function and is derived from A1) or a protein which has more than 80% of homology with the protein shown in A1); and A3) adding a tag protein to the terminal of the protein shown in A1) to obtain the fusion protein.VIGS is adopted to silence the DhLCYB gene, so that the color change effect of the dendrobium nobile is remarkable, different plants and different flowers are different in performance, and the dendrobium nobile fusion protein is high in ornamental value and interestingness.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of molecular biology and biotechnology and relates to Dendrobium DhLCYB Gene and its application of instantaneous regulation of flower color, especially a method of using DhLCYB A method to genetically change the color of Dendrobium flowers instantly. Background Art

[0002] Dendrobium is a species of the genus Dendrobium ( Dendrobium ) plants, most of which have ornamental value. Dendrobium has bright colors, diverse flower shapes, and a long shelf life. It is widely used in cut flowers, potted flowers, corsages, bouquets, and tableware flowers. The color of commercial Dendrobium is mainly purple-red, with a small amount of yellow, green, and white, and lacks pure red, orange, and sky blue. According to previous studies, the flower pigments of Dendrobium are divided into three categories: anthocyanins, carotenoids, and chlorophyll. Anthocyanins are the main pigments in Dendrobium, controlling the formation of purple, pink, peach, and other colors. Carotenoids are the main pigments in yellow flowers, and the superposition of anthocyanins and carotenoids makes the flower color brown-red. Cultivating novel flower colors and coloring patterns is a hot topic in Dendrobium color breeding research, and biological breeding will provide more possibilities for Dendrobium color breeding.

[0003] Carotenoids are the most important group of isoprene metabolites, existing in different compositions and contents in fruits, roots and flowers, absorbing visible light, resulting in yellow, orange and red colors. The biosynthesis of carotenoids in plants begins with isopentenyl pyrophosphate and its isomer dimethylallyl pyrophosphate, and the first rate-limiting enzyme on the main pathway is phytoene synthase (PSY). Next, the colorless phytoene undergoes a series of catalytic reactions to form red all-trans lycopene, which is the main pigment component of tomatoes and watermelons. The cyclization of lycopene is an important branch point in the biosynthesis of carotenoids, and the process is catalyzed by two lycopene cyclases: lycopene- ε -Lycylcyclase (LCYE) and lycopene- β -Cyclase (LCYB). Lycopene is produced by LCYE δ -Carotene, catalyzed by LCYB, is produced with β - Ring β -Carotene. The two ends of the lycopene molecule are catalyzed by LCYB and LCYE to form β -Ring and ε - Ring α -Carotene. LCYB The gene is considered to be a key node in changing the metabolic flow of carotenoids. LCYB Gene research reports.

[0004] VIGS (virus-induced gene silencing) is a method of introducing foreign genes into plants, which leads to the specific degradation of endogenous mRNA sequences that are highly homologous to the foreign genes, and then studies the function of target genes through phenotypic variation. It has been widely used in ornamental plants such as chrysanthemum, lily, peony, pansy, and daffodil. Summary of the invention

[0005] The technical problem solved by the present invention is to provide DhLCYB The application of genes and VIGS technology to transiently change the color of Dendrobium orchids.

[0006] In order to solve the above technical problems, the present invention provides a protein in the first aspect, which is any one of the following: A1) a protein comprising the amino acid residues shown in Sequence 2 in the sequence listing; A2) a protein derived from A1) with the amino acid sequence shown in SEQ ID NO. 2 being replaced and / or deleted and / or added with one or more amino acid residues and having the same function, or a protein having more than 80% homology with the protein shown in A1); A3) A fusion protein is obtained by adding a tag protein to the end of the protein shown in A1).

[0007] In the above, A1) is specifically a protein composed of the amino acid residues shown in Sequence 2 in the sequence listing.

[0008] In a second aspect, the present invention provides a nucleic acid molecule encoding the protein described in the first aspect.

[0009] The nucleic acid molecule described above is any of the following: B1) The coding gene includes the DNA molecule shown in Sequence 1 in the sequence list; B2) A DNA molecule that hybridizes with the DNA sequence defined in B1) under stringent conditions and encodes a protein with the same function; B3) A DNA molecule that has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% homology with the DNA sequence defined in B1) and encodes a protein with the same function.

[0010] In a third aspect, the present invention provides a recombinant vector, an expression cassette or a recombinant bacterium containing the nucleic acid molecule described in the second aspect.

[0011] In a fourth aspect, the present invention provides the use of the protein described in the first aspect, the nucleic acid molecule described in the second aspect, or the recombinant vector, expression cassette or recombinant bacteria described in the third aspect in regulating the flower color of Dendrobium orchid.

[0012] In a fifth aspect, the present invention provides the use of a substance that inhibits the biological function of the protein described in the first aspect or a substance that inhibits the expression of the nucleic acid molecule described in the second aspect in any of the following or in cultivating a plant having any of the following phenotypes: C1) Change the color of Dendrobium orchid flowers; C2) Increase the lycopene content in Dendrobium orchids; C3) Increase the redness of the petals of Dendrobium orchids; C4) Make individual Dendrobium orchid plants have different flower colors.

[0013] The above mentioned method of increasing the redness of the petals of Dendrobium orchid is reflected in the hue of the petals. a * Value increased.

[0014] In the above application, the substance is a VIGS carrier; The target sequence of the VIGS vector is the 959-1062 bp position of sequence 1 or corresponds to the 959-1062 bp position of sequence 1, or the 1149-1297 bp position of sequence 1 or corresponds to the 1149-1297 bp position of sequence 1.

[0015] Furthermore, the VIGS vector is a vector obtained by inserting the fragment shown at 959-1062 bp of sequence 1 or corresponding to 959-1062 bp of sequence 1, or 1149-1297 bp of sequence 1 or corresponding to 1149-1297 bp of sequence 1 into the pCymMV-pro60 vector.

[0016] In a sixth aspect, the present invention provides a method for changing the flower color of a Dendrobium orchid, comprising the following steps: inhibiting the biological function of the protein described in the first aspect in the Dendrobium orchid orchid orchid orchid orchid orchid orchid inhibiting the expression of the nucleic acid molecule described in the second aspect in the Dendrobium orchid orchid to obtain a Dendrobium orchid with changed flower color.

[0017] The above method for changing the flower color of Dendrobium orchid specifically comprises the following steps: D1) constructing a VIGS vector; the target sequence of the VIGS vector is sequence 1 or the 959-1062 bp position corresponding to sequence 1 or sequence 1 or the 1149-1297 bp position corresponding to sequence 1; D2) transferring the VIGS vector into Agrobacterium to obtain recombinant bacteria; D3) introducing the recombinant bacteria into the leaves of the Dendrobium orchid whose flower color is to be changed, thereby inhibiting the biological function of the protein described in the first aspect in the Dendrobium orchid orchid orchid orchid orchid orchid orchid orchid orchid orchid orchid expression of the nucleic acid molecule described in the second aspect, culturing, and obtaining the Dendrobium orchid with changed flower color.

[0018] In the above method, the Dendrobium orchid with changed flower color has more flower color varieties, higher redness of flower color and / or higher lycopene content than the Dendrobium orchid with changed flower color.

[0019] In the above step D3), the introduction time is when the Dendrobium orchid to be changed in color has an inflorescence of 10-15 cm and the flower buds are not open.

[0020] In the above text, the Dendrobium orchid whose flower color is to be changed is the yellow Golden Princess.

[0021] In a seventh aspect, the present invention provides a method for increasing the lycopene content in Dendrobium orchid, comprising the following steps: inhibiting the biological function of the protein described in the first aspect in Dendrobium orchid ...

[0022] In each of the above methods, the inhibition of the biological function of the DhLCYB protein in the Dendrobium orchid or the inhibition of the expression of the DhLCYB protein encoding gene in the Dendrobium orchid is achieved by introducing a VIGS vector into the Dendrobium orchid; The VIGS vector is a vector obtained by inserting sequence 1 or a fragment corresponding to the 959-1062 bp position of sequence 1 or sequence 1 or a fragment corresponding to the 1149-1297 bp position of sequence 1 into the pCymMV-pro60 vector.

[0023] The present invention provides DhLCYB Gene sequence information, and for DhLCYB Gene fragment construction DhLCYB -pCymMV-pro60 recombinant VIGS vector and its inserted fragment sequence. The gene fragment provided by the present invention is obtained from Dendrobium orchid. DhLCYB A sequence of the gene CDS coding region was obtained by reverse transcription RT-PCR, and the gene fragment was inserted into the pCymMV-pro60 vector to construct the VIGS vector, which was then transferred into Agrobacterium and injected into the yellow flower variety Dendrobium. After the first flower with a color change bloomed about 21 days later, every flower on the inflorescence had a color change until the whole flower aged and withered. If there were still unopened flower buds 50 days after the injection, the color of the flowers that bloomed would return to normal.

[0024] The experiments of the present invention prove that the present invention adopts VIGS silencing DhLCYB Genes can significantly change the color of Dendrobium orchids, and different plants and flowers have different performances, which are highly ornamental and interesting. Injection of leaves does not damage the flowers, and the flowering morphology is normal without deformity. The color change effect is long-lasting. The first flower with a changed color can bloom 20-25 days after injection. After that, each flower on the inflorescence will have a color change until the whole flower ages and withers. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 For the construction of VIGS vector DhLCYB Schematic diagram of the insert fragment.

[0026] Figure 2 For silence DhLCYB The flower phenotype of 'Golden Princess'.

[0027] Figure 3 For different treatments DhLCYB Silence effect.

[0028] Figure 4 For silence DhLCYB Then the color changes.

[0029] Figure 5 For silence DhLCYB Lycopene content. DETAILED DESCRIPTION

[0030] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.

[0031] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0032] Unless otherwise specified, the quantitative tests in the following examples were performed three times and the results were averaged.

[0033] The pCymMV-pro60 vector was kindly provided by Professor Wen-Chieh Tsai of the Institute of Tropical Plant Sciences, National Cheng Kung University, Taiwan, and is described in the following literature: Lu et al., 2012, A High-ThroughputVirus-Induced Gene-Silencing Vector for Screening Transcription Factors inVirus-Induced Plant Defense Response in Orchid, Molecular Plant-MicrobeInteractions, 25(6): 738–746.

[0034] Embodiment 1, method for changing the color of Dendrobium orchid instantly 1. Dendrobium DhLCYB Gene cloning Take the Dendrobium variety 'Jin Tong' ( Dendrobium Thongchai Gold) (plant purchased from Hainan Oriental Canaan Orchid Industry Co., Ltd.) flower buds were used as materials, and total RNA was extracted using the Tiangen Polysaccharide and Polyphenol Plant Total RNA Extraction Kit. The ToloScript RT EasyMix for qPCR (with 2-Step gDNA Erase-Out) (Shanghai Tolo Biotechnology Co., Ltd.) reverse transcription kit was used to synthesize cDNA, which was used as the amplification template.

[0035] Design full-length CDS amplification primers: LCYBF1: 5'-AATCTTCCTTCAACAGCTTCTC-3'; LCYBR1: 5'-CCTAATATTCTCCATCCCTCAAC-3'.

[0036] Using cDNA as template and LCYBF1 and LCYBR1 as primers, PCR amplification was performed to obtain DhLCYB Gene PCR amplification products.

[0037] The reaction program of the above PCR amplification was 95℃ 3 min, 95℃ 30 S, 60℃ 30 S, 72℃ 1 min30 S, 35 cycles, 72℃ 10 min. The DNA polymerase used was Vazyme 2 × Phanta Max Master Mix (purchased from Nanjing Novozyme Biotechnology Co., Ltd.). Amplification system: Mix 10 μL, forward primer and reverse primer 0.5 μL each, template cDNA 0.5 μL, and make up the total system to 20 μL with sterile water. DhLCYB The gene PCR amplification product was subjected to 1% agarose electrophoresis, the target band was recovered and cloned into the pMD 18-T vector to obtain DhLCYB -pMD18-T recombinant plasmid and sequenced.

[0038] DhLCYB Gene PCR amplification products have DhLCYB Genes, among which DhLCYB The nucleotide sequence of the gene is sequence 1, the protein encoded by the gene is named DhLCYB, and the amino acid sequence of the protein is sequence 2.

[0039] 2. VIGS vector construction 1. Obtaining the inserted fragments DhLCYB-1 to DhLCYB-5 The primer pairs are as follows: LCYBVF1:5'-ACCCACAACGATCTCCTTCC-3', LCYBVR1: 5'-GAGACGGAGGTGCTGGATAG-3'; LCYBVF2: 5'-TTCATCAACGACGCCAACTC-3', LCYBVR2: 5'-TGGATTGGTGGAAGCGGAC-3'; LCYBVF3: 5'-TGCCTTATCCGCTACGACAA-3', LCYBVR3: 5'-CGCTGCTTGAGTTCAGGAC-3'; LCYBVF4: 5'-GAATGGTTGAGCGGTTGAGG-3', LCYBVR4: 5'-CTGAGGAAGCACAGGGAGAG-3'; LCYBVF5: 5'-CGTTGCGGATGCCATTGTT-3', LCYBVR5: 5'-CCTCCAGATCCAGCCTCAGA-3'; The F and R primers of each pair of primers above are respectively added with adapters oh B1:GGGGACAAGTTTGTACAAAAAAGCAGGCT and oh B2: GGGGACCACTTTGTACAAGAAAGCTGGGT (F primer adds adapter oh Add adapter to the 5' end of B1, R primer oh B2).

[0040] by DhLCYB -pMD18-T plasmid was used as template, and the above-mentioned linkers were added oh B1 and connector oh The PCR products were amplified with primers B2, and the PCR products were the following 5 homologous fragments: containing the inserted fragment DhLCYB-1, containing the inserted fragment DhLCYB-2, containing the inserted fragment DhLCYB-3, containing the inserted fragment DhLCYB-4, and containing the inserted fragment DhLCYB-5: homologous fragments to B1-DhLCYB-1- to B2, homologous fragments to B1-DhLCYB-2- to B2, homologous fragments to B1-DhLCYB-3- toB2, homologous fragments to B1-DhLCYB-4- to B2 and homologous fragments to B1- DhLCYB-5- to B2.

[0041] The PCR reaction program was 95°C for 4 min, 95°C for 30 S, 60°C for 30 S, 72°C for 20 S, 35 cycles, and 72°C for 5 min.

[0042] The above amplification reaction system: Vazyme2 × Phanta Max Master Mix (purchased from Nanjing Novozyme Biotechnology Co., Ltd.) 10 μL, forward primer with adapter and reverse primer with adapter each 0.5 μL, template cDNA 0.5 μL, and sterile water to make up the total system to 20 μL.

[0043] 2. Construction of VIGS vector Using Gate V TM BP Master Mix [China-US Taihe Biotechnology (Beijing) Co., Ltd.] The above five homologous fragments were homologously recombined into the pCymMV-pro60 vector to obtain five recombinant plasmids.

[0044] The above reaction system is as follows: 7 μL of PCR product, 1 μL of pCymMV-pro60 vector, 2 μL of BP Master Mix, 25 ℃ for 1 h, add 1 μL of proteinase K solution, and incubate at 37 ℃ for 10 min.

[0045] After the reaction, 10 μL of the five recombinant plasmids were transformed into Escherichia coli TOP 10 competent cells and cultured overnight in 100 μg / mL kanamycin-resistant LB medium until single colonies were formed. The correctness of the sequence of the insertion position of the recombinant plasmid was verified by sequencing after PCR detection. The correct recombinant plasmids were named as follows: recombinant plasmid 1 to recombinant plasmid 5, which are 5 VIGS vectors.

[0046] The recombinant plasmid 1 expressing DhLCYB-1 is composed of homologous fragments to B1-DhLCYB-1- to B2 homologous recombination into pCymMV-pro60 vector to P1 and to The plasmid obtained between the P2 sites expresses the inserted fragment DhLCYB-1; the nucleotide sequence of the DNA molecule shown in attB1-DhLCYB-1- attB2 is to B1 sequence, sequence 1 bp 19–167 (DhLCYB-1, sequence 3), and to B2 sequence composition.

[0047] The recombinant plasmid 2 expressing DhLCYB-2 is a plasmid in which the homologous fragment attB1-DhLCYB-2- attB2 is homologously recombined into the pCymMV-pro60 vector. to P1 and to The plasmid obtained between the P2 sites expresses the inserted fragment DhLCYB-2; the nucleotide sequence of the DNA molecule shown in attB1-DhLCYB-2- attB2 is to It consists of B1 sequence, 463-583 bp of sequence 1 (DhLCYB-2, sequence 4) and attB2 sequence.

[0048] The recombinant plasmid 3 expressing DhLCYB-3 is a plasmid in which the homologous fragment attB1-DhLCYB-3-attB2 is homologously recombined into the pCymMV-pro60 vector. to P1 and to The plasmid obtained between the P2 sites expresses the inserted fragment DhLCYB-3; the nucleotide sequence of the DNA molecule shown in attB1-DhLCYB-3- attB2 is to B1 sequence, 688-842 bp of sequence 1 (DhLCYB-3, sequence 5) and to B2 sequence composition.

[0049] The recombinant plasmid 4 expressing DhLCYB-4 is a plasmid in which the homologous fragment attB1-DhLCYB-4- attB2 is homologously recombined into the pCymMV-pro60 vector. to P1 and to The plasmid obtained between the P2 sites expresses the inserted fragment DhLCYB-4; the nucleotide sequence of the DNA molecule shown in attB1-DhLCYB-4- attB2 is to B1 sequence, 959-1062 bp of sequence 1 (DhLCYB-4, sequence 6) and to B2 sequence composition.

[0050] The recombinant plasmid 5 expressing DhLCYB-5 is to convert the homologous fragment to B1-DhLCYB-5-attB2 homologous recombination into pCymMV-pro60 vector to P1 and to The plasmid obtained between the P2 sites expresses the inserted fragment DhLCYB-5; the nucleotide sequence of the DNA molecule shown in attB1-DhLCYB-5- attB2 is to B1 sequence, 1149–1297 bp of SEQ ID NO: 1 (DhLCYB-5, SEQ ID NO: 7), and to B2 sequence composition.

[0051] Insert fragment size DhLCYB-1, DhLCYB-2, DhLCYB-3, DhLCYB-4, DhLCYB-5 and the original DhLCYB The position in the gene CDS sequence is Figure 1 shown.

[0052] 3. Transient expression of five recombinant plasmids mediated by Agrobacterium in Dendrobium 1. Preparation of recombinant bacteria The five recombinant plasmids 1 to 5 constructed in the above two were transformed into Agrobacterium competent GV3010 (pSoup) (purchased from Shanghai Weidi Biotechnology Co., Ltd.) by liquid nitrogen freeze-thaw method, and cultured on YEB solid resistance medium containing 100 μg / mL kanamycin and 50 μg / mL rifampicin until single colonies were formed. Single colonies were picked and cultured in YEB liquid resistance medium containing 100 μg / mL kanamycin and 50 μg / mL rifampicin (Shanghai Yuanye Biotechnology Co., Ltd., product number R30379) overnight until the bacterial solution was turbid, and the bacterial solution was detected by the above primers and PCR program to determine whether it contained the target plasmid. Positive recombinant bacteria 1 to 5 were obtained, and recombinant bacteria 1 expressed DhLCYB-1, recombinant bacteria 2 expressed DhLCYB-2, recombinant bacteria 3 expressed DhLCYB-3, recombinant bacteria 4 expressed DhLCYB-4, and recombinant bacteria 5 expressed DhLCYB-5.

[0053] The same method was used to transform the empty vector pCymMV-pro60 into the competent Agrobacterium GV3101 to obtain the empty vector recombinant bacteria, named GV3101 / pCymMV-pro60.

[0054] 2. Transient transfection 1) Preparation of transfection solution The bacterial suspensions of the positive recombinant bacteria 1 to 5 in 1 were respectively expanded and cultured in YEB liquid resistance medium. 600 nm When the value reached 0.8 or above, the cells were collected by centrifugation at 5000 rpm / min for 5 min, the YEB medium was removed, the cells were resuspended in MS medium, and the cells were centrifuged at 5000 rpm / min for 5 min again. The cells were collected and resuspended in MS medium (Beijing Solebow Technology Co., Ltd., Catalog No. M8522) and the OD was adjusted. 600 nm When the value reaches 1.0, a bacterial solution is obtained, and then acetosyringone with a final concentration of 100 μM is added to the bacterial solution. The solution is allowed to stand in the dark at room temperature for 30 min to obtain the transfected bacterial solutions of recombinant bacteria 1 to 5.

[0055] 2) Preparation of transfected plants The Dendrobium variety 'Golden Princess' (Den. Arcadia Jade) (the plant was purchased from Hainan Oriental Canaan Orchid Industry Co., Ltd.) was used as the plant material, and plants with 10-15 cm of inflorescence and unopened flower buds were selected. Flower buds longer than 1 cm were removed, and the young flower buds at the front of the inflorescence were retained to obtain the plants to be transfected.

[0056] 3) Injection transfection Using GV3101 / pCymMV-pro60 bacterial solution as negative control, the transfected bacterial solution of the above recombinant bacteria 1 to 5 was sucked with a 1 mL sterile syringe and injected into the back of the first leaf below the pedicel of the plant to be transfected obtained in 2) above, and 300 μL of bacterial solution was injected into each plant. The injected plant materials were maintained in an incubator at 25 ℃, light intensity of 20000 Lux, light / dark time of 16 h / 8h, and humidity of 85% until flowering. Five plants were injected with each transfected bacterial solution.

[0057] 3. Phenotypic observation About 21 days after the transfection solution of the recombinant bacteria 1 to 5 in the above 2 was injected into the flowers, the injected plants bloomed the first flower with a changed color (pink stripes appeared on the yellow petals and sepals), and the subsequent flower colors changed more obviously. The flowers with the changed color will maintain until they wither. If new flowers are still blooming 50 days after the injection, the color has recovered.

[0058] The gene silencing induced by the VIGS vectors with five inserted fragments into 'Golden Princess' had different effects on flower color changes, as shown below: The phenotypic results of 'Golden Princess' 25 days after injection are as follows Figure 2 As shown, LCYB -1-V to LCYB-5-V represent recombinant plasmids 1 to 5 expressing different inserted fragments, respectively; the flowers with different inserted fragments showed the following states: individual radial pink spots appeared on a few petals (indicated by arrows, DhLCYB -3 insert), most petals and sepals show radial pink patches (arrowheads, DhLCYB -4 insert fragment, transfer containing DhLCYB -5 insert), no significant change in flower color (transferred DhLCYB -1 insert fragment, transfer containing DhLCYB -2 insert fragment). It can be seen that DhLCYB -4 and DhLCYB The effect of the VIGS vector with -5 insert fragment on changing flower color was more obvious than that of other treatments.

[0059] 4. Molecular identification 25 days after the injection of the above three recombinant bacteria expressing each inserted fragment, the flower buds of 'Golden Princess' with a length of about 2.5 cm were taken as materials, and the total RNA was extracted using the Tiangen Polysaccharide and Polyphenol Plant Total RNA Extraction Kit. The total RNA was reverse transcribed into cDNA using ToloScript RT EasyMix for qPCR (with 2-Step gDNA Erase-Out) (Shanghai Tolo Biotechnology Co., Ltd.). The 2 × Q3 SYBR qPCR Master Mix (Universal) fluorescence quantitative kit (Shanghai Tolo Biotechnology Co., Ltd.) was used for analysis DhLCYB Gene expression levels in flower buds. Dendrobium 'Golden Princess' infected with empty vector recombinant bacteria GV3101 / pCymMV-pro60 was used as a control. Three strains of each line.

[0060] Real-time fluorescence quantitative PCR detection DhLCYB The primers used for the genes are as follows: LCYB-qF: 5′- GCTGCCTTATCCGCTACGACAA-3′; LCYB-qR: 5′-TTCCCGCTGCTTGAGTTCAGGAC-3′.

[0061] The amplification reaction program of real-time fluorescence quantitative PCR was as follows: 95°C for 3 min; 95°C for 10 s, 60°C for 30 s, for 40 cycles. DhLCYB Dendrobium officinale β -actin and TUA, two genes were used as internal reference for normalization, and 2 –△△CT The relative quantification of genes is expressed by the method. The primer sequence of the internal reference gene is: Actin-qF: 5′-GTCAGGGACATCAAGGAGAAG-3′, Actin-qR: 5′-TGGGCACCTAAATCTCTCAGC-3′; TUA-qF: 5′-CAAAGAAGATGCAGCCAACAAC-3′, TUA-qR: 5′-AAGACCAGTGCAGTTGTCAGCTA-3′.

[0062] The results are as follows Figure 3 As shown, LCYB -1-V to LCYB-5-V represent plants injected with recombinant plasmids 1-5 expressing different insert fragments. DhLCYB -4 and DhLCYBThe silencing effect of VIGS vector in -5 was more obvious than that in other treatments at the gene expression level, which was consistent with the phenotypic results.

[0063] Therefore, we can use DhLCYB -4 and DhLCYB -5 two insertion fragments were used for transient expression in Dendrobium orchid and achieved the change of flower color.

[0064] 5. DhLCYB Dendrobium flower color and lycopene content after instantaneous silencing Insert each of the above 3 fragments DhLCYB -3. DhLCYB -4 and DhLCYB 30 days after the recombinant bacteria were injected into 'Golden Princess', the color difference was measured using a NF555 colorimeter under C 2° light source using CIE L * a * b * Color parameters of petals and sepals of multiple color-changing flowers of Dendrobium orchid measured by colorimetric system: brightness L * and Hue a * , b * Value. The determination of lycopene content in petals and sepals was commissioned to Wuhan Maiwei Metabolic Biotechnology Co., Ltd. The specific steps are as follows: weigh 50 mg of the ground sample, add 0.5 mL of a mixed solution of n-hexane / acetone / ethanol (1:1:1, V / V / V) containing 0.01% BHT (g / mL), vortex at room temperature for 20 min, centrifuge at 4°C for 5 min, 12000 r / min, take the supernatant, repeat the extraction once, and centrifuge to combine the supernatant; after nitrogen blowing and concentration, re-dissolve with 100 μL of methanol / methyl tert-butyl ether solution (1:1, V / V), filter through a 0.22 μm membrane, and store in a brown injection bottle.

[0065] The data acquisition instrument system mainly includes: Ultra Performance Liquid Chromatography (ExionLC™xAD) and Tandem Mass Spectrometry (MS / MS, QTRAP® 6500 + ), and the chromatographic and mass spectrometric conditions of Krinsky et al. (2004) and Geyer et al. (2004) were used for analysis. Liquid chromatography: Column: YMC C 30(3 μm, 100 mm×2.0 mm); mobile phase: phase A, methanol / acetonitrile (1:3, V / V) containing 0.01% BHT and 0.1% formic acid; phase B, methyl tert-butyl ether (containing 0.01% BHT); gradient elution program: 0 min A / B is 100:0 (V / V), 3 min is 100:0 (V / V), 5 min is 30:70 (V / V), 9 min is 5:95 (V / V), 10 min is 100:0 (V / V), 11 min is 100:0 (V / V); flow rate is 0.8 ml / min; column temperature is 28°C, and injection volume is 2 μL.

[0066] The mass spectrometry conditions mainly include: atmospheric pressure chemical ionization source (APCI) temperature is 350 °C, and the curtain gas (CUR) is 25 psi. + In the process, each ion pair is scanned and detected according to the optimized declustering potential (DP) and collision energy (CE).

[0067] The results are as follows: Compared with the control pCymMV-pro60 vector, the expression DhLCYB- 4 to DhLCYB- 5 VIGS vector pairs DhLCYB After silence, the brightness of the petals L * The value has a decreasing trend. DhLCYB- 4After VIGS treatment, the hue of the petals a * The value was significantly higher than that of the control, indicating that the redness of the flower color increased; b * The value does not change significantly ( Figure 4 ).

[0068] Lycopene content test results: LCYB -1-V to LCYB-5-V represent plants injected with recombinant plasmids 1-5 expressing different inserted fragments; compared with the control pCymMV-pro60 vector (lycopene content is 0), DhLCYB- 1 to DhLCYB- Lycopene content was detected in petals and sepals of all treatments (petals and sepals were mixed). DhLCYB- 4 and DhLCYB- The content of treatment 5 was the highest ( Figure 5), indicating that after LCYB silencing, the cyclization of lycopene was blocked, resulting in increased accumulation of lycopene and causing the flower color to turn pink.

[0069] The present invention has been described in detail above. It will be apparent to those skilled in the art that the present invention may be implemented in a wide range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the present invention and without the need for unnecessary experimentation. Although the present invention provides specific embodiments, it should be understood that further improvements may be made to the present invention. In short, according to the principles of the present invention, this application intends to include any changes, uses or improvements to the present invention, including changes made by conventional techniques known in the art that depart from the scope disclosed in this application. Applications of some of the basic features may be made within the scope of the following appended claims.

Claims

1. Protein, any of the following: A1) a protein comprising the amino acid residues shown in Sequence 2 in the sequence listing; A2) a protein derived from A1) with the amino acid sequence shown in SEQ ID NO. 2 being replaced and / or deleted and / or added with one or more amino acid residues and having the same function, or a protein having more than 80% homology with the protein shown in A1); A3) A fusion protein is obtained by adding a tag protein to the end of the protein shown in A1).

2. A nucleic acid molecule encoding the protein of claim 1.

3. The nucleic acid molecule according to claim 2, characterized in that: The nucleic acid molecule is any of the following: B1) The coding gene includes the DNA molecule shown in Sequence 1 in the sequence list; B2) A DNA molecule that hybridizes with the DNA sequence defined in B1) under stringent conditions and encodes a protein with the same function; B3) A DNA molecule that has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% homology with the DNA sequence defined in B1) and encodes a protein with the same function.

4. A recombinant vector, expression cassette or recombinant bacterium containing the nucleic acid molecule according to claim 2 or 3.

5. Use of the protein according to claim 1, the nucleic acid molecule according to claim 2 or 3, or the recombinant vector, expression cassette or recombinant bacteria according to claim 4 in regulating the flower color of Dendrobium orchid.

6. Use of a substance that inhibits the biological function of the protein of claim 1 or a substance that inhibits the expression of the nucleic acid molecule of claim 2 or 3 in any of the following or in cultivating a plant having any of the following phenotypes: C1) Change the color of Dendrobium orchid flowers; C2) Increase the lycopene content in Dendrobium orchids; C3) Increase the redness of the petals of Dendrobium orchids; C4) Make individual Dendrobium orchid plants have different flower colors.

7. The use according to claim 6, characterized in that: The substance is a VIGS carrier; The target sequence of the VIGS vector is the 959th to 1062th bp position of sequence 1 or corresponds to the 959th to 1062th bp position of sequence 1 or the 1149th to 1297th bp position of sequence 1 or corresponds to the 1149th to 1297th bp position of sequence 1.

8. A method for changing the flower color of a Dendrobium orchid, comprising the steps of inhibiting the biological function of the protein of claim 1 in the Dendrobium orchid or inhibiting the expression of the nucleic acid molecule of claim 2 or 3 in the Dendrobium orchid to obtain a Dendrobium orchid with changed flower color.

9. The method according to claim 8, characterized in that: The Dendrobium orchid with changed flower color has more flower color varieties, a higher degree of redness of the flower color and / or a higher lycopene content than the Dendrobium orchid with flower color to be changed.

10. A method for increasing the lycopene content in Dendrobium orchid, comprising the following steps: inhibiting the biological function of the protein of claim 1 in Dendrobium orchid or inhibiting the expression of the nucleic acid molecule of claim 2 or 3 in Dendrobium orchid, thereby reducing the lycopene content in Dendrobium orchid.